You are here

Members

CEO Roundtable on Cancer Members

 Amgen, Inc.
    Amneal Pharmaceuticals
 Astellas Pharma Inc.
 AstraZeneca
    Avara
 Bayer HealthCare Pharmaceuticals Inc.
 Boehringer Ingelheim USA Corporation
 Bristol-Myers Squibb
 Celgene
 Cree
 Dana-Farber Cancer Institute
 Duke Health
 Eli Lilly and Company
 EMD Serono
    Evercore Partners
 GlaxoSmithKline
    Gurnet Point Capital
 Hatteras Venture Partners
 Helsinn Group
 Hogan Lovells US LLP
    Human Longevity, Inc.
 Independence Blue Cross
 IQVIA
 Johnson & Johnson
    Lenovo
    Merck & Co., Inc.
 Novartis
 Pappas Capital
 Pfizer, Inc.
 Quest Diagnostics
 RTI International
 Sanofi
 SAS
 State Farm Insurance Companies
 Takeda Oncology
    The MITRE Corporation
 The University of Texas MD Anderson Cancer Center
 U.S. Chamber of Commerce

 Gold Standard accredited organization

Honorary Members

The CEO Roundtable on Cancer is proud to recognize the efforts of the following individuals who have worked to advance the mission of the Roundtable and are, therefore, welcomed as Honorary Members:

  • David Brennan, Former CEO, AstraZeneca plc
  • Victor Dzau, MD, President, National Academy of Medicine
  • Mimi Hancock, PhD, Retired Partner, Spencer Stuart
  • Coach Mike Krzyzewski, Head Coach, Mens’ basketball, Duke University
  • Thomas Moran, Chairman, President and CEO, Mutual of America
  • Charles A. Sanders, MD, Chairman, Foundation for the National Institutes of Health
  • Robert Wise, President, Alliance for Excellent Education

U.S. Government Organizations

The CEO Roundtable on Cancer is proud to work with the following organizations within the United States Department of Health and Human Services:

US Department of Health and Human Services

  • National Institutes of Health (NIH)
  •  National Cancer Institute (NCI)
  • Food and Drug Administration (FDA)
  •  Centers for Disease Control and Prevention (CDC)
  • Centers for Medicare & Medicaid Services (CMS)

 Gold Standard accredited organization